|
 Our aim in this field is to develop the next generation of tools for customized delivery of therapies to specific regions in the body. In one project we are developing fusion peptides, antibody-peptide conjugates, and quantum dot-polypeptide assemblies as potential anti-cancer therapeutics.
In a second related project, we are investigating the effectiveness of using a VP22/Sindbis viral system to deliver apoptosis-inducing peptides to cancer cells.
In the third project, we have begun initial design of molecular robots capable of traversing the plasma and nuclear membranes in order to modify the genetic material within the cell.
Home > Research Intro > Drug Delivery and Novel Therapeutics
|
|
